E-ISSN: 2147-2688
Relation of Apathy to Motor and Non-motor Findings in Parkinson’s Disease
PDF
Cite
Share
Request
Original Article
VOLUME: 57 ISSUE: 2
P: 129-134
June 2019

Relation of Apathy to Motor and Non-motor Findings in Parkinson’s Disease

Med Bull Haseki 2019;57(2):129-134
DOI: 10.4274/haseki.galenos.2018.4457
Melek Gürbüz 1
Gönül Akdağ 2
Özge Arıcı Düz 3
Feriha Özer 4
Özlem Çokar 5
Lütfü Hanoğlu 2
1. Atatürk Devlet Hastanesi, Nöroloji Kliniği, Sinop, Türkiye
2. Kütahya Sağlık Bilimleri Üniversitesi, Evliya Çelebi Eğitim ve Araştırma Hastanesi, Nöroloji Kliniği, Kütahya, Türkiye
3. Medipol Üniversitesi Tıp Fakültesi, Nöroloji Anabilim Dalı, İstanbul, Türkiye
4. Koç Üniversitesi Tıp Fakültesi, Nöroloji Anabilim Dalı, İstanbul, Türkiye
5. İstanbul Haseki Eğitim ve Araştırma Hastanesi, Nöroloji Kliniği, İstanbul, Türkiye
No information available.
No information available
Received Date: 26.05.2018
Accepted Date: 24.07.2018
Publish Date: 27.03.2019
PDF
Cite
Share
Request

ABSTRACT

Aim:

It has been shown that motor symptoms, as well as non-motor symptoms, significantly affect the quality of life of patients with idiopathic Parkinson’s disease. In our study, the association of apathy, one of the NMS, with motor and non-motor symptoms was investigated.

Methods:

Patients with stage 1-3 IPH according to the Hoehn-Yahr Scale (H&Y) were included in the study. Patients who received dementia diagnosis according to the DSM IV criteria were excluded from the study. The patients were evaluated using the Unified Parkinson’s Disease Rating Scale (UPDRS), non-motor symptoms Questionnaire (NMSQ), Geriatric Depression Scale (GDS), and the revised diagnostic criteria for apathy.

Results:

Apathy was found in 26 of 68 patients who were included in the study. Patients with and without apathy were compared in terms of age, clinical and demographic characteristics, L-dopa equivalent doses, depression, and NMSQ scores. The group of patients with apathy consisted of nine females and 17 males and the mean age was 64.3±7.7 years. The non-apathy group included 25 females and 17 males and the mean age was 66.8±9.1 years. There was no statistically significant difference between the groups in terms of age, education, age at onset, duration of illness and L-dopa equivalent doses. The male-to-female ratio was significantly higher in the apathy group. The mean GDS and NMSQ scores in the apathy group were significantly higher than in the non-apathy group. There was a statistically significant difference between the groups in H&Y stage and total UPDRS and subscales scores. It was noteworthy that the rate of stage 3 patients was higher in the group of patients with apathy. The number of patients having bradykinesia in the apathy group and the number of patients having tremor in the group without apathy was higher.

Conclusion:

Our study showed that apathy, one of the non-motor symptoms, was more prominent in male gender, associated with UPDRS scores, clinical stage and bradykinesia, and accompanied by depression.

References

1McDonald WM, Richard IH, DeLong MR. Prevalence, etiology, and treatment of depression in Parkinson’s disease. Biol Psychiatry 2003;54:363-75.
2Rabinstein AA, Shulman LM. Management of behavioral and psychiatric problems in Parkinson’s disease. Parkinsonism Relat Disord 2000;7:41-50.
3Poewe W, Wenning G. The differential diagnosis of Parkinson’s disease. Eur J Neurol 2002;9:23-30.
4Dujardin K, Defebvre L. Apathy in Parkinson diseaseWhat are the underlying mechanisms? Neurology 2012;79:1082-83.
5Aarsland D, Marsh L, Schrag A. Neuropsychiatric symptoms in Parkinson’s disease. Mov Disord 2009;24:2175-86.
6Dujardin K, Sockeel P, Devos D, et al. Characteristics of apathy in Parkinson’s disease. Mov Disord 2007;22:778-84.
7Kirsch-Darrow L, Marsiske M, Okun MS, Bauer R, Bowers D. Apathy and depression: separate factors in Parkinson’s disease. J Int Neuropsychol Soc 2011;17:1058-66.
8Sockeel P, Dujardin K, Devos D, Deneve C, Destee A, Defebvre L. The Lille apathy rating scale: a new instrument for detecting and quanrifying apathy: validation in Parkinson’s disease. J Neurol Neurosurg Psychiatry 2006;77:579-84.
9Hoehn MM, Yahr MD. Parkinsonism: Onset, progression and mortality. Neurology 1967;17:427-42.
10Lang AET, Fahn S. Assessment of Parkinson’s disease. In MunsatTLed. Quantification of Neurologic Deficit. Stoneham: Butterworths, 1989.
11Starkstein SE, Mayberg HS, Preziosi TJ, Andrezejewski P, Leiguarda R, Robinson RG. Reliability, validity, and clinical correlates of apathy in Parkinson’s disease. J Neuropsychiatry Clin Neurosci 1992 Spring;4:134-9.
12Marin RS. Apathy: a neuropsychiatric syndrome. Journal of Neuropsychiatry and Clinical Neuroscience 1991;3:243-54.
13Chaudhuri KR, Martinez_Martin P, Schapira AHV, et al. International multicentre pilot study of the first comprehensive self-completed non motor symptoms questionnaire for Parkinson’s disease: The NMSQuest study. Mov Disorders. 2006;21:916-23.
14Yesavage JA, Brink TL, Rose TL, et al. Development and validation of a geriatric depression screening scale:a preliminary report. J Psychiatr Res 1982-1983;17:37-49.
15Dr. Turan Ertan. Geriatrik Depresyon Ölçeği ile Kendini Değerlendirme Depresyon Ölçeği’nin 60 yaş üzeri Türk populasyonunda geçerlilik ve güvenilirliği. Uzmanlık Tezi İ.Ü. Cerrahpaşa Tıp Fakültesi Psikiyatri Anabilim dalı İstanbul 1996.
16Güngen C, Ertan T, Eker E, Yaşar R, Engin F. Standardize Mini Mental Test’in Türk Toplumunda Hafif Demans Tanısında Geçerlilik ve Güvenilirliği. Türk Psikiyatri Dergisi 2002;13:273-81.
17Chaudhuri KR, Healy DG, Schapira AH. Non-motor symptoms of Parkinson’s disease: diagnosis and management.; National Institute for Clinical Excellence. Lancet Neurol 2006;5:235-45.
18Kirsch-Darrow L, Fernandez HH, Marsiske M, Okun MS, Bowers D. Dissociating apathy and depression in Parkinson disease. Neurology 2006;67:33-8.
19Pedersen KF, Larsen JP, Alves G, Aarsland D. Prevalence and clinical correlates of apathy in Parkinson’s disease: a community-based study. Parkinsonism Relat Disord 2009;15:295-9.
20Isella V, Melzi P, Grimaldi M, et al. Clinical, Neuropsychological, and Morphometric Correlates of Apathy in Parkinson’s Disease. Movement Disorders 2002;17:366-71.
21Varanese S, Perfetti B, Ghilardi MF, Di Rocco. A Apathy, but not depression, reflects inefficient cognitive strategies in Parkinson’s disease. PLoS One 2011;6(3):17846.
22Reijnders JS, Scholtissen B, Weber WE, Aalten P, Verhey FR, Leentjens AF. Neuroanatomical Correlates of Apathy in Parkinson’s Disease: A Magnetic Resonance Imaging Study Using Voxel-Based Morphometry. Mov Disord 2010;25:2318-25.
23Marin RS, Firinciogullari S, Biedrzycki RC. The sources of convergence between measures of apathy and depression. J Affect Disord 1993;28:117-24.
24Levy ML, Cummings JL, Fairbanks LA, et al. Apathy is not depression. J Neuropsychiatry Clin Neurosci 1998;10:314-9.
25Crosiers D, Pickut B, Theuns J, et al. Non-motor symptoms in a Flanders-Belgian population of 215 Parkinson’s disease patients as assessed by the Non-Motor Symptoms Questionnaire. Am J Neurodegener Dis 2012;1:160-7.
26Moretti R, Torre P, Antonello RM, et al. Apathy: a complex symptom specific to the clinical pattern of presentation of Parkinson’s disease? Am J Alzheimers Dis Other Demen 2012;27:196-201.
Article is only available in PDF format. Show PDF
2024 ©️ Galenos Publishing House